Full-Time

Life Sciences Consultant

India

ClearView Healthcare Partners

ClearView Healthcare Partners

501-1,000 employees

Life sciences strategy consulting for biopharma

No salary listed

Noida, Uttar Pradesh, India

Hybrid

Hybrid role; 100% in-office onboarding/training, then ~50% in-office schedule.

Category
Consulting (1)
Requirements
  • Ability to independently manage activities across multiple workstreams (e.g., storylines, ghosting documents, data gathering) and able to provide thought partnership for more ambiguous or complex projects
  • Strong written and oral communication skills in English
  • Well-positioned to serve as a mentor for junior team members
  • Enthusiasm for working in a dynamic, fast-paced, and collaborative team environment
  • Proficient in Microsoft Office Suite (e.g. Outlook, Excel, PowerPoint, etc.)
  • Requires and seeks support for more complex projects or difficult client situations
  • Highly analytical and structured approach to solving complex problems
  • Undergraduate or Master’s degree in the life sciences or equivalent
  • Minimum three years of experience in life sciences consulting
Responsibilities
  • Interact with clients and ClearView teams to address critical strategic questions within the biopharmaceutical space
  • Conduct complex problem-solving through a hypothesis-based approach
  • Create templated outputs to support overall project deliverable
  • Able to conduct a straightforward project or workstream with moderate oversight
  • Create and utilize analytic tools (e.g., forecast models) to support key decision-making
  • Communicate recommendations to clients to inform strategy and maximize value
ClearView Healthcare Partners

ClearView Healthcare Partners

View

ClearView Healthcare Partners provides strategic consulting services exclusively for the life sciences sector, guiding pharmaceutical, biotechnology, medical devices, and diagnostics firms through decisions from discovery to commercialization. It completes project work with 100% of a dedicated team focused on a single client engagement, pairing rigorous scientific knowledge with business strategy, with many consultants holding life sciences PhDs. The firm differentiates itself through its strict one-client-per-project model, sector-only focus, and deep scientific expertise, plus international expansion to serve global clients. Its goal is to help life sciences companies grow, advance product development, and secure market access, creating value across the entire product lifecycle.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Newton, Massachusetts

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • Gurgaon office expands Asia-Pacific client reach since 2025.
  • $4M Epistemic AI investment enhances AI-driven biomedical analysis.
  • 330 employees position as largest independent life sciences consultancy.

What critics are saying

  • Founder departures destabilize leadership post-GHO 2021 acquisition.
  • Pharma M&A cuts consulting budgets through 2025.
  • McKinsey life sciences hires poach PhD consultants immediately.

What makes ClearView Healthcare Partners unique

  • 100% project team dedication ensures focused life sciences strategy.
  • Over half consultants hold life sciences PhDs for scientific rigor.
  • Exclusive focus on pharma, biotech, medtech growth strategies.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at ClearView Healthcare Partners who can refer or advise you

Benefits

Hybrid Work Options

Remote Work Options

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Wellness Program

Mental Health Support

Professional Development Budget

Conference Attendance Budget

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Home Office Stipend

Phone/Internet Stipend

Parental Leave

Adoption Assistance

Meal Benefits

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Training Programs

Company News

PR Newswire
Mar 12th, 2025
The Addf'S Diagnostics Accelerator Authors New Paper On Ocular Biomarker Landscape, Highlighting Ocular Tests As A Tool For Early Detection Of Alzheimer'S Disease

New findings published in Alzheimer's Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's, while ocular tests offer a non-invasive alternative for detecting at-risk patient populations NEW YORK, March 12, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) authored a first-of-its-kind paper, "Unlocking ocular biomarkers for early detection of Alzheimer's disease," providing a landscape review of ocular biomarkers as another tool, alongside blood biomarkers, to aid in the early detection of Alzheimer's disease. The paper, which was published in Alzheimer's Dementia, shares an informed perspective on the role of ocular biomarkers in the broader Alzheimer's diagnostics space and what defines a true ocular biomarker, while also highlighting the potential for ocular screening to identify at-risk patients who would otherwise go undiagnosed. The authors' assessment is based on hours of in-depth interviews with leading neurologists, ophthalmologists, optometrists, and primary care physicians from across the United States

CityBiz
Jan 13th, 2025
ClearView Invests $4M in Epistemic AI

ClearView Healthcare Partners announced a $4 million minority investment in Epistemic AI to enhance its EpistemicGPT platform, which combines AI with a vast biomedical knowledge graph. This partnership aims to improve ClearView's service offerings by integrating AI technology, enhancing research and drug development processes. The collaboration underscores a commitment to advancing biomedical research and healthcare outcomes through innovative technology solutions.

CityBiz
Jan 13th, 2025
ClearView Healthcare Partners Invest In Epistemic AI

BOSTON, MA and WESTPORT, CT – 13 January 2025: ClearView Healthcare Partners, the leading life sciences strategic consultancy supporting Pharma... Read More

Digital Therapeutics Alliance
Nov 15th, 2023
DTx Commercialization Launch Playbook Case Study

Digital Therapeutics Alliance is thrilled to announce the release of its latest white paper in collaboration with Clearview Healthcare Partners!

Foundation Fighting Blindness
Feb 13th, 2023
The Foundation's long-term impact on moving the inherited retinal disease field forward towards treatments and cures. — Foundation Fighting Blindness

The Foundation Fighting Blindness partnered with ClearView Healthcare Partners to evaluate the impact of its funding and resources since 2005 on the clinical understanding and development of novel therapies for inherited retinal diseases (IRDs).